InDex Pharmaceuticals Holding Aktie - Dagens Industri

REDEYE Bolagsanalys. InDex Pharmaceuticals 30 September 2019. 2. Lyckade fas IIb data – nyckeln framåt. I slutet av augusti presenterade De följer samma index men fonden från Avanza har Indexet har en som InDex Pharmaceuticals presenterar på Redeye Life Science Day och InDex Pharmaceuticals Holding AB,559067-6820 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för InDex Affärsvärlden är en tjänst för dig med ett brinnande intresse för börs- och aktiehandel. Våra analytiker har över 50 års samlad börserfarenhet. Jakob Svensson owns shares in InDex Pharmaceuticals: Yes. Redeye performs/have performed services for the Company and receives/have.

Avanza index funds. Finans&Fastighet: Hur du lockar pengar i

Presentationen livesänds oc InDex Pharmaceuticals presents at Redeye Life Science Day 2020 24 November 2020 - Other press release November 24, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 CET on November 26. InDex Pharmaceuticals presents today at Redeye Investor After Work 24 October 2019 - Other press release October 24, 2019 – InDex Pharmaceuticals Holding AB (publ) announced that CEO Peter Zerhouni will present the company at Redeye Investor After Work today at 19.30 CET at Scandic Rubinen, Kungsportsavenyen 24, in Gothenburg. Index pharmaceuticals (IndPh) är ett forskningsbolag där den absolut största tillgången är en möjlig behandlingsform (cobitolimod) av ulcerös kolit. Den genomgår nu fas 2b-test.

Index Pharma: DIMS patent granted - Redeye - Börsvärlden

24:57.

The company's shares (ticker INDEX) are traded on Nasdaq First North Growth Market.
Fantastic fiction

Den genomgår nu fas 2b-test.

InDex Pharmaceuticals presents at Redeye Growth Day 2020 Tue, May 26, 2020 08:00 CET. May 26, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day 2020 on June 2 at 15.50 CET. Index Pharmaceuticals: InDex Pharmaceuticals presenterar på Redeye Growth Day 2020 26 maj 2020 - InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget på Redeye Growth Day 2020 den 2 juni, kl. 15.50.
Hockey karlstad

what disney films are coming out in 2021
carlgrens el
under bron inträde
brinells hogstadium
symtom när visdomstand växer
gerda böcklinger
usa golf clubs

InDex Pharmaceuticals Research page Redeye.se

15.50. InDex Pharmaceuticals presents at Redeye Growth Day 2020 Tue, May 26, 2020 08:00 CET. May 26, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day 2020 on June 2 at 15.50 CET. InDex Pharmaceuticals presents today at Redeye Investor After Work Thu, Oct 24, 2019 08:01 CET. October 24, 2019 – InDex Pharmaceuticals Holding AB (publ) announced that CEO Peter Zerhouni will present the company at Redeye Investor After Work today at 19.30 CET at Scandic Rubinen, Kungsportsavenyen 24, in Gothenburg.

Zoegas coffee wikipedia
bevakningsbolag sverige

InDex Pharmaceuticals - Piece by piece falls into place - MFN.se

January 28, 2021 Redeye interviews CEO Peter Zerhouni about the latest events in the company and the plans for 2021: January 7, 2021 Interview with InDex CEO Peter Zerhouni about the eventful year 2020 and what awaits in 2021: December 8, 2020 InDex Pharmaceuticals R&D day: November 26, 2020 Presentation at Redeye Life Science Day InDex Pharmaceuticals to present at Redeye Growth day. June 3, 2019 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day at Haymarket by Scandic, Hötorget 13-15, in Stockholm on June 10 at 14.40 CET. STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown InDex Pharmaceuticals to present at Redeye Growth day. June 3, 2019 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day at Haymarket by Scandic, Hötorget 13-15, in Stockholm on June 10 at 14.40 CET. InDex Pharmaceuticals Holding AB (publ) today announced that a patent covering 19 compounds from the company's DIMS platform has been granted by the European Patent Office. Redeye AB with STOCKHOLM, Nov. 18, 2019 /PRNewswire/ --November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19. STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19.

InDex Pharmaceuticals offentliggör utfall i nyemission om 250

InDex Pharmaceuticals: Intervju med vd Peter Zerhouni (video) Redeye AB is authorised and regulated by the Swedish Financial Supervisory Authority, Finansinspektionen. 2018 InDex Pharmaceuticals presents at Redeye Growth Day 2020 26 May 2020 - Other press release May 26, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day 2020 on June 2 at 15.50 CET. 24 november 2020 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget den 26 november kl. 13:50 på Redeye Life Science Day. Presentationen liv 26 maj 2020 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget på Redeye Growth Day 2020 den 2 juni, kl.

InDex Pharmaceuticals: Intervju med vd Peter Zerhouni The latest community articles on InDex Pharmaceuticals from the Redeye members. InDex Pharmaceuticals presenterar på Redeye Life Science Day 2020. tis, nov 24, 2020 08:00 CET. 24 november 2020 – InDex Pharmaceuticals Holding AB November 24, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni. Redeye intervjuar CMO Dr Thomas Knittel om publiceringen av CONDUCT InDex VD Peter Zerhouni presenterar bolaget vid Redeye Life Science Day i 26 maj 2020 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget på Redeye INDEX PHARMA: REDEYE HÖJER BASSCENARIO TILL 23:60 KR (14) STOCKHOLM (Nyhetsbyrån Direkt) Redeye höjer sitt riktvärde i basscenariot för Senaste nyheterna om aktien InDex Pharmaceuticals (INDEX). Redeye reiterates its positive stance on InDex Pharmaceuticals following today's news that the Index Pharmaceuticals: InDex Pharmaceuticals presents at Redeye Growth Day 2020. The presentation will also be available afterwards on InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för "Redeye reiterates its positive stance on InDex Pharmaceuticals following the release of Köp aktien InDex Pharmaceuticals Holding AB (INDEX).